Cargando…
Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study
Dual antiplatelet treatment is currently the mainstay of pharmacologic treatment for patients after coronary percutaneous interventions for stable or acute coronary syndrome. The treatment decreases the incidence of thrombotic complications, but is responsible for an increased risk of bleeding. The...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7270912/ https://www.ncbi.nlm.nih.gov/pubmed/32523438 http://dx.doi.org/10.1093/eurheartj/suaa058 |